This article refers to 'A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction' by D. Popovic et al., published in this issue on pages 1115-1124.
Oxygen consumption/ work rate trajectory
In this issue of the Journal, Popovic and colleagues have attempted to further phenotype the HF syndrome along the newly proposed three subsets of populations differentiated by left ventricular ejection fraction [HF with reduced (HFrEF), mid-range (HFmrEF) and preserved ejection fraction (HFpEF)]. 4 The study was conducted retrospectively by using data from a large CPET registry. The results show that patients with VO 2 flattening present with more severe signs of HF, higher New York Heart Association (NYHA) class, higher levels of N-terminal pro brain natriuretic peptide (NT-proBNP), higher pulmonary artery systolic pressure (PASP), The lower tricuspid annular plane systolic excursion (TAPSE) and a shorter 6-min walking distance. These results were similar in the three subsets of patients with HFpEF (n = 198), HFmrEF (n = 80) and HFrEF (n = 41).
The authors also found that patients who showed VO 2 flattening presented more frequently with a reduced TAPSE/PASP ratio in resting transthoracic echocardiography than patients without VO 2 flattening (0.36 ± 0.15, n = 92 vs. 0.56 ± 0.18, n = 227, P < 0.001). They conclude that the occurrence of VO 2 flattening at the end of CPET is due to a similar pathophysiologic pathway involving a depression of TAPSE relative to PASP at rest.
In this study, VO 2 flattening was found to be a significant univariate predictor of primary (all-cause death, LVAD implantation and HTx) and secondary outcome (cardiac death, rehospitalization for cardiac reasons, LVAD implantation and HTx). It also significantly predicted mortality from cardiac causes, defined as either sudden death or death due to pump failure. However, the study was not designed to investigate cardiac death as a single parameter.
In a multivariate analysis of CPET parameters, including VO 2 flattening, peak VO 2 , minute ventilation/carbon dioxide production (VE/VCO 2 ) slope and EOV but not including NYHA class, 6-min walking distance, NT-proBNP or echocardiographic parameters, VO 2 flattening and EOV were the only independent predictors of the primary outcome and cardiac death. The secondary outcome was predicted independently by VO 2 flattening, peak VO 2 and EOV.
While they have failed to better phenotype HF with this new parameter, Popovic and colleagues shed some additional light onto the causes of exercise limitation and potentially on the prognosis, independent of left ventricular ejection fraction. The proposed parameter of the VO 2 trajectory slope might represent a limitation of cardiac output through right ventricular failure during exercise. While right ventricular function is established as a potential important determinant of exercise capacity and mortality in HFrEF, 5 this is less well established in HFpEF. However, right ventricular dysfunction as measured by load-dependent parameters such as TAPSE or right ventricular fractional area change (FAC), or by efforts to account for afterload in these measurements by dividing the parameters by the calculated PASP (TAPSE/PASP or FAC/PASP), has been shown to occur in about 20% of patients with HFpEF. The authors show that these patients exhibit a flattening of the VO 2 trajectory similar to that of patients with HFmrEF or HFrEF.
Several pleas for caution must be taken into account while interpreting these results.
Oxygen consumption trajectory flattening
While VCO 2 kinetics during exercise follow a triphasic response (aerobic CO 2 production/buffering by HCO 3 -/acidosis), VO 2 kinetics are usually completely linear. In some patients, however, this linearity is discontinued towards the end of exercise, giving way to a more gradual increase in oxygen uptake, which is termed VO 2 trajectory flattening or flattening of the ΔVO 2 /Δ work rate (WR) slope. Belardinelli et al. 6 described this deviation from linearity in the setting of ischaemia, Tanabe et al. 7 in that of HF. It has been linked to a failure of right-sided cardiac output in the setting of reduced longitudinal right ventricular systolic shortening, predominantly due to a massive rise in PASP during exercise in patients with HF. Consistently with this, the ΔVO 2 /ΔWR slope has also been shown to be flattened in patients with pulmonary arterial hypertension. 8 In principal, this shallower rise could be caused by any step from oxygen uptake to delivery and its use in providing aerobically generated high-energy phosphates. Nevertheless, the flattening of oxygen uptake has clinically shown best correlations to PASP or TAPSE/PASP. Given the complex interactions between the left and right ventricle, respiration and oxygen uptake as well as between cardiac output and VO 2 , it is not readily evident why the oxygen uptake trajectory slope should behave similarly in all aetiologies/subsets of HF. Nevertheless, the authors describe this phenomenon in patients with reduced, mid-range and normal ejection fraction at a frequency between 20% and 30% and as similarly predictive of primary and secondary outcomes. This is even more astonishing when one considers that pulmonary hypertension in HFpEF occurs almost regularly 9 and is found during exercise even in patients with normal resting haemodynamics, 10 while in HFrEF this is more variable.
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Flattening: a unique pathophysiology?
Given the possible mechanisms, a plea for caution should be issued about the authors' common pathway explanation. Ischaemia may play a more important role in HFrEF, 5 while the sharper rise in PASP may be the predominant mechanism in HFpEF. limitation of the left ventricle by ischaemia. Moreover, occult pulmonary embolism might play a role, since ventilation-perfusion scanning was not performed in the study patients. While the relatively high average PETCO 2 values do not point to a major component, this may nevertheless be part of the explanation. Independently of ejection fraction, however, the flattening might still contain information of prognostic importance to clinicians that indicates disease severity.
Flattening: a sign of right heart failure?
The attribution of a flattened VO 2 trajectory to right HF also has limitations in attributing comparable loading conditions to different patient subsets. Left-right ventricular interdependence and PASP are not the only factors affecting right ventricular contraction; pulmonary impedance does so as well, partly influenced by pulmonary arterial compliance. This makes it more difficult to attribute a compromised ejection parameter such as TAPSE or TAPSE corrected for PASP to contractile failure of the right ventricle. Since ventricular interdependence and arterial compliance are largely determined by left heart function, the sole attribution to right ventricular failure may be misleading, 12 though right ventricular stroke volume and cardiac output might be decreased.
While in HFrEF the optimal cardiac output is pumped at low filling pressure because the enlarged left ventricle can better translate tension development into volume work as its size is reduced, HFpEF is more preload-sensitive and dependent on high filling pressures to provide optimal use of the Frank-Starling mechanism. Overtreatment of these patients with diuretics might also easily lead to a relative underfilling of the right ventricle, also reducing right cardiac output.
Overall, the reduced cardiac output, whether it results from right or left cardiac output failure, is apparently reflected in flattening of the VO 2 trajectory and is an important marker of disease severity and therefore prognosis.
Prognostic aspects
While VO 2 trajectory flattening might be a helpful tool for detecting an increased risk of adverse events in HF patients in general, the presented results phenotype HF only from a CPET viewpoint. Even though VO 2 flattening was a predictor of higher adverse event rates in the multivariate analysis, this analysis failed to include several important parameters that are known to predict higher mortality in HF patients, such as NYHA class, 13 NT-proBNP, 14 6-min walking distance, 15 and others. It is thus unclear whether the high predictive value of VO 2 flattening would remain if these already established parameters were to be considered as well.
Other factors that predict prognosis in HF should not necessarily be discarded. VO 2 and VE/VCO 2 slope have been proven to be of high predictive value in a number of trials and have been successfully used in clinical practice for well over a decade. Judgment of prognostic aspects of HF will always integrate anamnestic, clinical, laboratory, echocardiographic and CPET parameters as well as
